Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
506.00    4.00 (0.80%)
Bid:
502.00
Ask:
506.00
Spread: 4.00 (0.797%)
Market Cap: £833.71m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Holding(s) in Company

20 Jun 2017 12:42

RNS Number : 6181I
Oakley Capital Investments Limited
20 June 2017
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

Oakley Capital Investments Limited

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the notification obligation: iii

Ruffer LLP (for its discretionary clients of the Ruffer Group)

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date on which the threshold is crossed or reached: v

15 June 2017

6. Date on which issuer notified:

16 June 2017

7. Threshold(s) that is/are crossed or reached: vi, vii

17% to 16%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

 

BMG670131058

35,056,724

35,056,724

34,634,084

34,634,084

-

16%

-

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

34,634,084

16%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

Ruffer LLP controls the voting rights over 34,634,084 shares (now 16% of the voting rights) of Oakley Capital Investments Limited, which are held by the discretionary clients of Ruffer LLP and its subsidiaries (the voting of which is all controlled by Ruffer LLP).

This change from 17% to 16% is due to the sale of 422,640 shares on 15 June 2017

14. Contact name:

Louise Stanway

15. Contact telephone number:

020 7963 8146

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFMMBTMBITBMR
Date   Source Headline
1st May 20197:00 amRNSAcquisition of stake in Rastreator and Acierto
5th Apr 20192:45 pmRNSHolding(s) in Company
2nd Apr 20192:00 pmRNSKepler Trust Intelligence: New Research
25th Mar 20197:00 amRNSAcquisition of Ekon
15th Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20197:00 amRNSShare buy-back
14th Mar 20197:00 amRNSAnnual Results for the Year Ended 31 December 2018
6th Mar 20194:53 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSTrading update for the year ended 31 December 2018
3rd Jan 20197:00 amRNSCapital Commitment
14th Nov 20183:58 pmRNSDirector Dealing
8th Nov 20187:00 amRNSInvestment Activity Update
24th Oct 20181:30 pmRNSDirector Dealing
12th Oct 20183:07 pmRNSDirector Dealing
25th Sep 20187:00 amRNSAppointment of Non-Executive Director
11th Sep 20187:00 amRNSBoard Changes
6th Sep 20187:00 amRNSHalf-year Report
21st Aug 20187:00 amRNSOakley Capital to invest in cPanel
27th Jul 20184:40 pmRNSHolding(s) in Company
26th Jul 20187:00 amRNSTrading Update
6th Jul 20187:00 amRNSOakley agrees sale of Damovo to Eli Global
4th Jul 20183:49 pmRNSResult of AGM
28th Jun 20186:21 pmRNSDirector Dealing
28th Jun 20186:20 pmRNSDirector Dealing
26th Jun 201811:29 amRNSDirector Dealing
21st Jun 20187:00 amRNSNotice of Annual General Meeting
11th Jun 20187:00 amRNSPlesk acquisition of SolusVM
24th May 20187:00 amRNSOakley agrees sale of Facile to EQT
26th Apr 20184:05 pmRNSHolding(s) in Company
26th Apr 20184:05 pmRNSHolding(s) in Company
26th Apr 20183:35 pmRNSDirector/PDMR Shareholding
26th Apr 20183:34 pmRNSDirector/PDMR Shareholding
13th Apr 20182:00 pmRNSDirector/PDMR Shareholding
20th Mar 201812:54 pmRNSDividend Announcement
15th Mar 20187:00 amRNSFinal Results
6th Mar 201811:57 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSSale of PARSHIP ELITE Group and Verivox
31st Jan 20187:00 amRNSTrading Update
18th Jan 20185:26 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSAcquisition of Career Partner Group
19th Sep 20177:00 amRNSDirector/PDMR Shareholding
15th Sep 20178:57 amRNSDirector/PDMR Shareholding
12th Sep 20177:00 amRNSHalf-year Report
3rd Aug 20177:00 amRNSTrading Update
31st Jul 20177:00 amRNSChange of Stock Ticker
28th Jul 20177:00 amRNSInspired welcomes TA Associates as an investor
10th Jul 20173:10 pmRNSCompletion of Schülerhilfe Acquisition
20th Jun 201712:42 pmRNSHolding(s) in Company
16th Jun 201711:03 amRNSResult of AGM
26th May 20177:00 amRNSCompletion of TechInsights Acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.